Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quidelortho Corp
(NQ:
QDEL
)
42.25
-1.33 (-3.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quidelortho Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
April 13, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
March 28, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
March 08, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
March 02, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
March 01, 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via
MarketBeat
Topics
Initial Public Offering
Exposures
COVID-19
Product Safety
Securities Market
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
February 15, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 06, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
December 28, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
December 16, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
December 12, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Host Investor Day on December 13, 2022
November 30, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Third Quarter 2022 Financial Results
November 02, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
October 12, 2022
From
QuidelOrtho Corporation
Via
Business Wire
Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation
October 04, 2022
From
Quidel Corporation
Via
Business Wire
QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
September 06, 2022
From
QuidelOrtho Corporation
Via
Business Wire
Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community
September 01, 2022
From
Quidel Corporation
Via
Business Wire
Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation
August 24, 2022
From
Quidel Corporation
Via
Business Wire
QuidelOrtho Announces $300 Million Share Repurchase Authorization
August 17, 2022
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Second Quarter 2022 Financial Results
August 04, 2022
From
QuidelOrtho Corporation
Via
Business Wire
Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County
June 21, 2022
From
QuidelOrtho Corporation
Via
Business Wire
Quidel Corp.—Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test—To Partner With Renowned Global Lyme Alliance to Dramatically Heighten Lyme Disease Awareness
June 09, 2022
From
Quidel Corporation
Via
Business Wire
QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics
May 27, 2022
From
QuidelOrtho Corporation
Via
Business Wire
Quidel and Ortho Announce Expected Closing of Ortho Transaction
May 26, 2022
From
Quidel Corporation
Via
Business Wire
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination
May 16, 2022
From
Quidel Corporation
Via
Business Wire
Quidel Reports First Quarter 2022 Financial Results
May 04, 2022
From
Quidel Corporation
Via
Business Wire
Quidel to Hold Fiscal First Quarter 2022 Financial Results Conference Call on May 4th, 2022
April 12, 2022
From
Quidel Corporation
Via
Business Wire
Quidel Announces Preliminary Revenue for First Quarter 2022
April 07, 2022
From
Quidel Corporation
Via
Business Wire
Quidel Reports Fourth Quarter and Full Year 2021 Financial Results
February 17, 2022
From
Quidel Corporation
Via
Business Wire
Quidel to Hold Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 17th, 2022
February 01, 2022
From
Quidel Corporation
Via
Business Wire
Quidel Announces Preliminary Revenue for Fourth Quarter 2021
January 06, 2022
From
Quidel Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.